中文产业新闻精选评分76Chinese source
国内首个国产原研BCMA×CD3双抗纬利妥米单抗获NMPA附条件批准
复星医药血液瘤再添“利器”！首个国产原研BCMA/CD3双抗获批
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
复星医药血液瘤再添“利器”！首个国产原研BCMA/CD3双抗获批
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.